Results: Of 867 drugs with 3 or more reports, 101 drugs met all criteria using disproportionality analysis and indicated a potential risk of pancreatitis
The drugs high demand has caused a global shortage, which is expected to continue well into 2024.
Notably, compared to GLP-1 RAs, the use of DPP-4 inhibitors showed a higher correlation with more severe outcomes, including death, highlighting their potential risks
Bryan Gawley, MDSkin is setting a new standard for safety, clinical excellence, and client experience
Furthermore, glutathione has clinical applications in treating liver diseases, treating kidney diseases, providing chemoprotection, and preventing vascular dementia
Herbst KL, Amory JK, Brunzell JD, Chansky HA, Bremner WJ